Osaka, Japan

Wataru Ohtani


Average Co-Inventor Count = 7.5

ph-index = 7

Forward Citations = 103(Granted Patents)


Location History:

  • Hirakata, JP (1994)
  • Osaka, JP (1987 - 1999)

Company Filing History:


Years Active: 1987-1999

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Wataru Ohtani: Innovator in Recombinant Human Serum Albumin

Wataru Ohtani is a prominent inventor based in Osaka, Japan, renowned for his significant contributions to the field of biotechnology. Holding an impressive portfolio of 10 patents, Ohtani has made remarkable advancements, particularly in the production and purification of recombinant human serum albumin.

Latest Patents

Ohtani's latest patented innovations include a process for producing recombinant human serum albumin through gene manipulation techniques. This novel process involves several purification steps designed to ensure the final product is a pure form of human serum albumin, free from proteinous and polysaccharide contaminants. Key steps in the purification process involve ultrafiltration, heat treatment, acid treatment, and advanced chromatography techniques, which collectively enhance the quality and safety of the pharmaceutical preparation. Moreover, Ohtani has developed methods for decoloring human serum albumin, ensuring that the recombinant product remains visually free from undesirable coloration caused by contaminating substances.

Career Highlights

Ohtani is currently associated with The Green Cross Corporation, a company recognized for its dedication to the biotechnology sector. Through his work, he has exemplified how innovation can lead to improved healthcare solutions. His extensive research and patent activity reflect his commitment to advancing the science behind human serum albumin, which is crucial for various medical applications, including drug formulation and intravenous therapies.

Collaborations

Throughout his career, Ohtani has collaborated with talented colleagues such as Takao Ohmura and Akinori Sumi. These partnerships have played a crucial role in his research initiatives and have fostered an environment of innovation and creativity within his field.

Conclusion

Wataru Ohtani’s contributions to biotechnology, specifically in recombinant human serum albumin production and purification, demonstrate the potential of innovative research to enhance medical treatments. His work not only emphasizes the importance of purity and safety in biopharmaceuticals but also highlights the collaborative efforts that drive technological advancements in medicine. With a strong patent portfolio and a commitment to research excellence, Ohtani continues to shape the future of biotechnology for improved health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…